Health product recall

JAMP-ATORVASTATIN: The affected lot may contain latex.

Last updated

Summary

Product
JAMP-ATORVASTATIN
Issue
Health products - Contamination
What to do

Contact your pharmacy to confirm if you are taking medication from the affected lot. If you are, stop taking it and return it to your pharmacy for a replacement product and proper disposal.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
JAMP-ATORVASTATIN JAMP-ATORVASTATIN DIN 02391074 Tablet ATORVASTATIN (ATORVASTATIN CALCIUM) 40 mg MHC1403A

Issue

Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.

Atorvastatin is a prescription drug used to treat high cholesterol and other fats (such as triglycerides) in the blood, and to prevent cardiovascular disease such as heart attacks.

Ingesting latex can pose serious health risks for people with latex allergies, including severe allergic reactions (anaphylaxis). Symptoms of anaphylaxis include breathing difficulties, nausea, vomiting, and low blood pressure. Anaphylaxis can be life threatening. In addition, foreign material in the tablets may change their shape, which could make them difficult to swallow and lead to choking.

The Department is monitoring the company’s recall and will inform Canadians if any new health risks are identified.

What you should do

  • Contact your pharmacy to confirm if you are taking medication from the affected lot. If you are, stop taking it and return it to your pharmacy for a replacement product and proper disposal.
  • Contact Jamp Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at serviceclient@jamppharma.com, if you have questions about this recall.
  • Report any health product adverse events or complaints to Health Canada.

Additional information

Previous recalls or alerts
Background

Depth of recall: Wholesalers, Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Jamp Pharma Corporation

1310 Nobel, Boucherville

QC, J4B 5H3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-64451